Olivier Loeillot is a highly experienced professional who has held various leadership roles in the biopharmaceutical industry. Currently serving as the President & CCO at Repligen Corporation, Olivier has also worked at companies such as ILC Dover, Ascensus Specialties, Cytiva, GE Healthcare, LONZA AG, and Rhodia Pharma Solutions. With a background in engineering and an MBA in finance, Olivier has a proven track record of driving sales growth, managing large teams, and successfully leading multiple business units and divisions.
Current role